| Leonard Sigal, | |
|
125 Paterson St, Clinical Academic Building - Suite 5200a, New Brunswick, NJ 08901-1962 | |
| (732) 235-7217 | |
| Not Available |
| Full Name | Leonard Sigal |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 125 Paterson St, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790850444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MA51908 (New Jersey) | Primary |
| Entity Name | Berkshire Faculty Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548212939 PECOS PAC ID: 8224068424 Enrollment ID: O20050817001122 |
News Archive
GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Double Eagle Holdings, Ltd. announced today that it has successfully completed the acquisition of Fuse Science, Inc. Under the terms of the acquisition agreement, Fuse Science becomes a wholly-owned subsidiary of Double Eagle, effectively repositioning Double Eagle as an innovation-based consumer products holding company.
Scientists at the Institute for Systems Biology (ISB), in collaboration with researchers from New York University (NYU), have developed a model which rapidly characterizes and accurately predicts the molecular-level, mechanistic response of a free-living cell to genetic and environmental changes.
AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.
Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leonard Sigal, 66 W Gilbert St, 2nd Floor, Tinton Falls, NJ 07701-4947 Ph: (732) 212-0051 | Leonard Sigal, 125 Paterson St, Clinical Academic Building - Suite 5200a, New Brunswick, NJ 08901-1962 Ph: (732) 235-7217 |
News Archive
GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.
Double Eagle Holdings, Ltd. announced today that it has successfully completed the acquisition of Fuse Science, Inc. Under the terms of the acquisition agreement, Fuse Science becomes a wholly-owned subsidiary of Double Eagle, effectively repositioning Double Eagle as an innovation-based consumer products holding company.
Scientists at the Institute for Systems Biology (ISB), in collaboration with researchers from New York University (NYU), have developed a model which rapidly characterizes and accurately predicts the molecular-level, mechanistic response of a free-living cell to genetic and environmental changes.
AbbVie, a global biopharmaceutical company, today announced that a Phase 2 trial of its investigational medicine venetoclax met its primary endpoint of achieving overall response rates in patients with relapsed/refractory or previously untreated chronic lymphocytic leukemia (CLL) with 17p deletion, according to an independent review analysis.
Two-time Emmy and Tony award-winning actress Judith Light and the National Council on Aging (NCOA) are teaming up for the second year on the national educational initiative Flu + You to educate older adults and those who care for them about the seriousness of influenza ("the flu"), the importance of prevention and available vaccine options.
› Verified 6 days ago
Jennifer Waldmann, M.D Rheumatology Medicare: Medicare Enrolled Practice Location: 254 Easton Ave, New Brunswick, NJ 08901 Phone: 732-996-6741 | |
Lokesh Lahoti, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-823-3000 | |
Dr. Imran Khan, M.D., PH.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 125 Paterson St, Suite 5200, New Brunswick, NJ 08901 Phone: 732-235-6531 | |
Dr. Robert Louis Wong, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St Ste 5100, New Brunswick, NJ 08901 Phone: 732-235-6583 Fax: 732-235-7238 | |
Eric A Rubin, Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 195 Little Albany St, New Brunswick, NJ 08901 Phone: 732-235-2465 | |
Haris Ishaque Rana, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 240 Easton Ave, New Brunswick, NJ 08901 Phone: 732-745-8564 Fax: 732-745-9156 | |
Amanda Borham, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Robert Wood Johnson Pl, New Brunswick, NJ 08901 Phone: 732-235-7794 Fax: 732-235-7238 |